FromJulie Anne Overton ([email protected])
Subject (65)bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
Preheader (149)News ReleasebioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024Expanded CyPath® Lung test sales to physicians in Illinois, Alabama, and
Arial
Text Analysis
Body Words2222
Subject Words9
Body Emojis19
Subject Emojis
Media Analysis
Text Links11
Image Links3
Total Links14
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px3919 px
X-Spam Score0.0
Preheader OptimizedNo
Timing
Day of WeekTuesday
TimeAfternoon
